Yongyuan Hesheng is a data-driven synthetic biology innovation company that takes long-segment DNA synthesis technology as its entry point. Established in 2022, the company adopts a revolutionary technological approach to establish a new generation of long-segment DNA synthesis platform, meeting the disruptive IT (Information Technology) + BT (Biotechnology) research and development paradigm needs, and driving the innovation of synthetic biology and genome engineering. The company is committed to promoting the revolution of synthetic biology research and development paradigm, and facilitating the exploration of the underlying laws of biology to truly realize the vision of using synthetic biology to benefit humanity.

     Corporate website: http://emergencesynbio.com/